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Summary
Background Mindfulness, defined as purposively and nonjudgementally paying
attention in the present moment, could be used within psychosocial interventions
to reduce the distress associated with social anxiety and avoidance found in many
skin conditions. However, little is known about the relationship between natu-
rally occurring levels of mindfulness and distress in dermatology patients.
Objectives To examine the relationship between mindfulness and psychosocial dis-
tress in a dermatological population. It was hypothesized that higher levels of
mindfulness would be associated with lower levels of social anxiety, anxiety,
depression and skin shame, and with better quality of life.
Methods Adult dermatology outpatients (n = 120) from one hospital completed
items assessing subjective severity, skin shame, fear of negative evaluation, anxi-
ety and depression, quality of life, and levels of mindfulness.
Results Considering depression, 14% reported mild, 5% moderate and 25% severe
symptoms. For anxiety, 22% reported mild, 23% moderate and 6% severe symp-
toms. In addition, 334% reported clinically significant social anxiety. After control-
ling for subjective severity, mindfulness explained an additional 19% of the
variance in depression, 39% in anxiety, 41% in social anxiety, 13% in skin shame
and 6% in dermatological quality of life. One specific facet of mindfulness (acting
with awareness) was found to be the most consistent predictor of distress.
Conclusions The findings indicate that higher levels of mindfulness are associated
with lower distress. This suggests that facilitating mindfulness may be helpful in
reducing distress in dermatology patients, and the use of mindfulness techniques
warrants further investigation.
What’s already known about this topic?
• Correlation studies suggest that higher levels of mindfulness are related to lower
levels of social anxiety.
• Studies indicate that mindfulness can be beneficial for people experiencing a range
of long-term health conditions.
• Mindfulness interventions have been beneficial in improving skin clearance and
severity in patients with psoriasis.
What does this study add?
• This is the first study to show that mindfulness accounts for a significant amount
of the variance in both psychological distress and quality of life in dermatology
patients.
• Mindfulness may play a particularly important role in social anxiety.
• The study suggests that facilitating the ‘ability to attend to the present moment’ is
a potential target for psychosocial interventions for patients distressed by their skin
condition.
© 2016 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists
British Journal of Dermatology (2016) 1
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
What are the clinical implications of this work?
• High levels of social anxiety, depression and anxiety highlight the need for psycho-
logical interventions to be available to dermatology patients.
• Mindfulness interventions could benefit people living with skin conditions who are
experiencing psychological distress – either as stand-alone low-intensity interven-
tions or incorporated into cognitive behavioural therapy.
• Using mindfulness to bring attention to the present moment may reduce self-
focused attention, which is a key characteristic of social anxiety.
Dermatological conditions can result in disability levels
equivalent to those of other chronic diseases, affecting self-
esteem, work and relationships.1 It is estimated that for at
least one-third of dermatology patients effective management
requires the management of psychosocial distress,2 with
85% of patients indicating that such factors are an impor-
tant aspect of living with a skin condition.3 Higher rates of
depression and anxiety have been reported by dermatologi-
cal cohorts in comparison with the general population.4,5
For example, people with psoriasis have reported high levels
of psychosocial disability and worrying about their appear-
ance.6 Similarly, high rates of anxiety have been found in
people with psoriasis and atopic eczema.7,8 Patients with
acne have been found to experience depression,2 social anx-
iety9 and increased thoughts of suicide.10 Increased levels of
anxiety, depression and phobic reactions have also been
reported by people living with alopecia.11 There is a risk
that people living with a skin condition can experience dis-
tress during social situations,12 which can result in avoid-
ance of social encounters.13
For people living with a visible skin condition there is a
real risk of experiencing actual negative reactions from
others.14,15 People have reported cases of discrimination such
as being asked to leave public places.16 Not surprisingly, high
levels of self-consciousness have been described by some peo-
ple living with visible conditions, and self-consciousness has
been reported to be related to avoidant coping strategies.15
For example, people living with alopecia often attempt to con-
ceal hair loss, using a variety of methods.17 Anxiety is known
to be associated with specific forms of cognitive processing
such as attentional and appraisal biases, whereby the individ-
ual is at risk of misinterpreting responses of others.18
Patients with psoriasis have been found to demonstrate
biases towards negative self-referential words (e.g. embarrass,
ugly), reactions of others (e.g. ridicule, whisper) and condi-
tion-specific information (e.g. itching, messy) in comparison
with controls.19 Indeed, functional magnetic resonance imag-
ing studies suggest that patients with psoriasis may block
emotional processing when seeing faces showing disgust, as a
coping strategy to protect them from stressful emotional
responses.20 Similarly, in acne a recent eye-tracking study
demonstrated that participants exhibited an attentional bias
towards acne lesions in comparison with controls.21
Given the prevalence of psychosocial distress in dermatol-
ogy patients and the potential role of attentional and inter-
pretative bias in maintaining negative mood states,22,23
interventions that reduce attentional bias are likely to be ben-
eficial. Despite the clear need, access to psychological inter-
ventions within dermatology in general is limited.3,12 A
meta-analysis of psychological interventions identified a med-
ium effect size (g = 054)24 for interventions; however, the
interventions that have been tested are largely limited to sim-
ple techniques focusing on specific behavioural problems.
Relatively few interventions have targeted social anxiety,
despite this being a common problem reported by people
living with skin conditions. The present study aims to exam-
ine the extent to which mindfulness can explain levels of
distress, particularly those associated with self-consciousness
(shame and social anxiety) in people living with skin
conditions.
Mindfulness is defined as ‘paying attention in a particular
way: on purpose, in the present moment, non-judgementally
to the unfolding experience.’25 It has been proposed that
mindfulness consists of five distinct facets.26 Observing relates
to a tendency to notice internal and external sensations, and
awareness concerns the extent to which individuals feel able
to attend to the present moment, in contrast to ‘mind wander-
ing’. Nonjudgement of experiences concerns the ability to take
a nonevaluative stance towards thoughts; describing examines
the tendency to label experiences; and finally, nonreactivity to
inner experience refers to the tendency to allow thoughts to
come and go without responding.
Mindfulness interventions have been used with patients liv-
ing with psoriasis with promising results.27,28 Kabat-Zinn
et al.27 reported that improved skin clearing in patients with
psoriasis using mindful meditations during light treatment
was a result of reductions in stress. Patients with psoriasis have
also reported improved dermatological quality of life and self-
assessed psoriasis severity28 following mindfulness-based cog-
nitive therapy. However, no reduction in stress levels was
observed, suggesting that stress reduction was not the mecha-
nism of change. While there is evidence that mindfulness
interventions are effective with other physical health prob-
lems, it remains unclear what the underlying mechanisms
are.29 It is therefore important to examine the different facets
of mindfulness and their relationship with distress. To date,
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research assessing mindfulness interventions on psychosocial
distress in dermatology patients has considered only psoriasis.
This study examined the relationship between mindfulness
and psychosocial distress in people living with a range of visi-
ble skin conditions. It was hypothesized that higher levels of
mindfulness would be associated with lower levels of social
anxiety, anxiety, depression and skin shame, and with better
dermatology-specific quality of life.
Patients and methods
Ethical approval was gained from the National Health Service,
Tyne and Wear South research ethics committee. Participants
were recruited from the dermatology department of a regional
teaching hospital in the U.K. The inclusion criteria were (i)
age > 16 years; (ii) a visible condition such as psoriasis,
eczema, dermatitis, acne or hair disorders; and (iii) having
sufficient English to complete the questionnaires and provide
informed consent. As the study focused on skin disease, pri-
mary psychiatric diagnoses affecting the skin (e.g. trichotillo-
mania, delusions of parasitosis) and skin cancer were
excluded. Participants meeting the inclusion criteria were
invited to participate following their dermatology consultation.
Participants could complete the questionnaires in the clinic or
at home. Questionnaires completed in the clinic were com-
pleted independently in the waiting room and returned to
reception.
Data analysis
Firstly, data were analysed to determine clinically significant
levels of anxiety, depression and social anxiety using cut-off
scores. Secondly, associations were tested between demo-
graphic variables (age, sex, ethnicity), clinical variables (type
of skin condition, area of body affected, subjective severity),
mindfulness and psychosocial distress (social anxiety, anxiety,
depression, skin shame and dermatological quality of life)
using t-tests, ANOVA or correlations as appropriate. Thirdly,
hierarchical regressions were conducted to examine the
amount of variance in psychosocial distress explained by the
five facets of mindfulness. Demographic and clinical variables
found to be associated with psychological distress were
entered at step one, followed by the five facets of mindfulness
at step two.
Participants
Of the 180 patients approached, 120 agreed to participate in
the research (67% response rate). Reasons for declining to
participate were not collected. The participants were predomi-
nantly female and white. The most frequently reported skin
conditions were psoriasis, eczema, alopecia and acne. Partici-
pants not reporting their skin condition might not yet have
been provided with their diagnosis. Table 1 lists full details of
the sample.
Measures
Mindfulness
Mindfulness was assessed using the Five Facet Mindfulness
Questionnaire.26 The measure comprises 39 items measuring
five facets of mindfulness: observing (eight items), describing
(eight items), acting with awareness (eight items), nonjudge-
ment of inner experience (eight items) and nonreactivity to
inner experience (seven items). The items are rated on five-
point Likert scales and responses to each facet are summed.
The individual subscales had good reliability in this study (see
Table 2).
Subjective severity
In order to examine participants’ perceptions of the severity of
their skin condition, visibility and impact on daily life, partici-
pants were asked to indicate, on five-point scales, the extent
to which they felt their skin condition affected their life, how
visible it was, and whether they received negative comments.
Scores on these items were summed to provide a total score.
Participants also reported the area of the body affected.
Skin shame
The Skin Shame Scale (Scott, unpublished thesis) measures an
individual’s personal experience of skin distress. It is based on
models of shame relating to dermatology and disfigurement
and consists of 24 questions rated on five-point response
scales. It has been reported to be a reliable (Cronbach
a = 092) and valid measure.30,31
Table 1 Sample characteristics
Characteristic Value
Skin condition, n (%)
Eczema, dermatitis, prurigo
and Netherton syndrome
22 (183)
Acne, rosacea and dissecting cellulitis 19 (158)
Psoriasis 25 (208)
Alopecia 20 (167)
Other inflammatory skin conditions 8 (67)
Other 17 (142)
Not reported 9 (75)
Sex, n (%)
Male 35 (292)
Female 84 (700)
Not reported 1 (08)
Ethnicity, n (%)
White 104 (867)
Asian or Asian British 5 (42)
Black or black British 1 (08)
Other 8 (67)
Not reported 2 (17)
Age (years), mean  SD 459  184
Age at onset (years), mean  SD 136  147
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Social anxiety
The Brief Fear of Negative Evaluation straightforward
items32–34 was used to assess social anxiety. It consists of eight
statements that participants are asked to rate on five-point
response scales. Cronbach a-values for clinical, control and
combined samples have been reported at 092, 090 and 096,
respectively.34 A cut-off score of 25 was used to identify indi-
viduals experiencing symptoms of social anxiety disorder.33
Anxiety and depression
The Hospital Anxiety and Depression Scale35 comprises seven
items assessing anxiety and seven items assessing depression,
rated on four-point response scales. A score of eight or above on
either scale indicates presence of anxiety or depression symp-
toms, with 15 or above indicating severe anxiety or depression
symptoms. It has been widely used in psychiatric, primary-care
and general populations.35 It has good psychometric properties
(Cronbach a for anxiety = 083 and depression = 080).36
Dermatological quality of life
The DLQI37 consists of 10 items concerning the impact of the
skin condition over the last week rated on four-point Likert
scales. Items relate to symptoms and feelings, daily activity,
leisure, work/school, personal relationships and side-effects of
treatment. The DLQI has good validity, reliability and respon-
siveness to change.38
Results
Demographic variables
Associations between age, sex, age of onset, type of skin con-
dition and psychological outcomes were examined. Age was
the only demographic variable significantly correlated with
social anxiety, r(117) = 029, P = 0002; dermatologi-
cal quality of life, r(113) = 021, P = 0025; and skin
shame, r(116) = 025, P = 0007.
Psychological distress variables
Scores on outcome variables were examined to establish the
prevalence of anxiety, depression and social anxiety. For
depression, 77% reported no symptoms, 14% reported mild,
5% moderate and 3% severe symptoms of depression. For
anxiety, 47% reported no symptoms, 22% mild, 23% moder-
ate and 6% severe symptoms. Clinically significant levels of
social anxiety were reported by 334% of the sample. Over
half of the sample (517%) reported the skin condition having
some effect on their quality of life, with 267% reporting a
very large or extremely large effect.
Subjective severity
Subjective severity was significantly positively correlated
with skin shame, r(117) = 065, P < 0001; depression, r
(118) = 049, P < 0001; anxiety, r(119) = 042, P < 0001;
dermatological quality of life, r(114) = 066, P < 0001; and
social anxiety, r(118) = 041, P < 0001. Thus, higher levels
of subjective severity were related to higher levels of psy-
chosocial distress.
Area of body affected by the skin condition
Participants who indicated that their skin condition affected
their head had significantly higher levels of social anxiety,
t(116) = 244, P = 003 and higher levels of depression, t
(116) = 246, P = 002. Participants whose skin condition
affected their arms reported significantly higher levels of
depression, t(116) = 222, P = 0028, and poorer dermato-
logical quality of life, t(112) = 307, P = 0003. In
addition, participants whose skin condition affected their
hands, t(112) = 423, P < 0001; legs, t(112) = 357,
P = 0001; and feet, t(112) = 230, P = 0024 reported sig-
nificantly lower dermatological quality of life.
Mindfulness and psychosocial distress
Correlations between mindfulness and measures of psycholog-
ical distress are presented in Table 3. The results highlight dif-
ferent patterns of associations between individual facets of
mindfulness and psychosocial distress. ‘Describe’, ‘act with
awareness’ and ‘nonjudgement of inner experience’ were neg-
atively correlated with all measures of psychological distress.
Higher levels of mindfulness on these three facets were related
to lower levels of skin shame, social anxiety, anxiety, depres-
sion and dermatological quality of life. In addition, ‘observe’
was positively correlated with social anxiety and anxiety.
‘Nonreactivity to inner experience’ was not significantly corre-
lated with any of the dependent variables.
A series of hierarchical regression analyses was conducted
to examine the amount of variance in psychological outcomes
explained by the five facets of mindfulness (Table 4). As sub-
jective severity was significantly correlated with all of the psy-
chological outcomes, it was controlled for in the regression
Table 2 Means, SDs and internal reliabilities of the main study
variables
Variable Mean SD Alpha
Skin shame 6959 1798 092
Social anxiety 2077 873 095
Depression 480 380 081
Anxiety 785 444 084
Dermatological quality of life 800 714 089
Describe 2655 601 083
Observe 2256 623 077
Awareness 2922 612 087
Nonreactivity 2038 613 086
Nonjudgement 2954 693 089
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analyses. The regression analyses were repeated controlling for
other demographic variables correlated with specific outcomes;
however, the results were unchanged. For the sake of brevity
and consistency, only the analyses controlling for subjective
severity are reported.
After controlling for subjective severity, mindfulness explained
additional variance in skin shame, DR2 = 013, DF(5,101) = 556,
P < 0001; social anxiety, DR2 = 041, DF(5,101) = 2009,
P < 0001; anxiety, DR2 = 039, DF(5,101) = 2009, P < 0001;
depression, DR2 = 019, DF(5,100) = 606, P < 0001; and der-
matological quality of life, DR2 = 006, DF(5,99) = 231,
P = 005. Act awareness was the most consistent predictor and was
significant in all regression analyses except for quality of life. In addi-
tion, describe was a significant predictor of skin shame, observe was
a significant predictor of quality of life, and nonjudgement was a
significant predictor of social anxiety.
Discussion
High levels of anxiety, depression and social anxiety were docu-
mented in the present sample of dermatology patients, therefore
adding to the literature highlighting the need for psychological
support.1–17 The present results also suggest that people living
with visible skin conditions who report higher levels of mind-
fulness report lower levels of psychosocial distress and better
quality of life, across a range of different skin conditions.
Regression analyses indicated that mindfulness explained
6–41% of the variance in psychosocial distress. Higher levels
of both present-moment awareness and nonjudgement of
inner experience were associated with lower levels of social
anxiety. These results suggest that individuals with high levels
of social anxiety are paying less attention to the present
moment. Acting with awareness could reduce the tendency to
engage in rumination, which has been found to maintain dis-
tress.39 Cognitive models of social phobia propose that social
anxiety is maintained by attentional and interpretative
biases.22,40 Attention is focused on internal processes, and the
individual becomes less engaged with the social situation.22,40
Previous findings of bias towards negative self-referential
information in patients with psoriasis suggest that reducing
attentional bias would be beneficial in reducing symptoms of
social anxiety in people with skin conditions.
Individuals reporting higher levels of awareness also
reported lower levels of depression and anxiety. With regards
to depression, Teasdale et al.39 proposed that if cognitive
resources are deployed in the present moment this decreases
the resources available for ruminative processing. Given the
role that rumination plays in maintaining other disorders,22
this might explain the mechanism by which acting with
awareness might operate, although this supposition requires
further investigation.
While mindfulness was significantly associated with quality
of life, the pattern of results differed from the other psychoso-
cial variables. ‘Observe’, the facet concerning the tendency to
notice internal and external sensations, was not related in the
direction expected, as higher scores related to more
Table 3 Correlations between mindfulness and measures of psychological distress
Skin shame Social anxiety Anxiety Depression Quality of life
Describe 033** 037** 028** 027** 022*
Observe 007 024* 019* 013 012
Awareness 037** 064** 065** 046** 022*
Nonreactivity 005 003 004 006 011
Nonjudgement 035** 063** 053** 042** 025**
*P < 005, **P < 001.
Table 4 Summary of regression analyses of variables predicting psychological outcomes
Skin shame Social anxiety Anxiety Depression Quality of life
b b b b b b b b b b
Step 1
Subjective severity 064*** 058*** 044*** 030*** 041*** 028*** 045*** 036*** 066*** 063***
Step 2
Describe 023** 012 006 007 014
Observe 002 003 009 008 019*
Awareness 019* 038*** 053* 032** 009
Nonreactivity 0001 009 018* 013 013
Nonjudgement 004 026*** 013 011 003
DR2 042*** 013*** 019*** 041*** 017*** 039*** 020*** 019*** 044*** 006*
*P < 005, **P < 001, ***P < 0001.
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impairment in quality of life. This may be particularly relevant
to dermatology patients, given that they may experience
unpleasant physical sensations due to their condition or be
using unpleasant emollients or treatments. The differential pat-
tern of results for ‘observe’ has been found in previous stud-
ies.41 It may suggest that increased attention to emotions and
distress in the absence of a nonjudgemental attitude could lead
to an increase in distress.41
Participants reporting higher ‘nonreactivity to experience’
experienced lower levels of anxiety. Previous studies suggest
that nonreactivity is a key component of mindfulness, given
the role it plays in reducing negative automatic emotional
responding.42 Nonreactivity may be particularly relevant for
dermatology patients who experience distressing physical
symptoms related to their condition, or negative thinking
related to their appearance. Lower levels of awareness were
related to higher levels of skin shame, suggesting that partici-
pants are acting on automatic pilot and are more likely to
engage with habitual patterns of negative thinking characteris-
tic of depressive mood states.41 The relationship between ‘de-
scribe’ and skin shame may suggest that individuals who are
able to describe their experiences in an objective manner are
likely to experience lower levels of skin shame.
Overall, the different pattern of relationships between
mindfulness facets and psychosocial distress suggests that not
all aspects of mindfulness may be important targets for modi-
fication in psychological interventions. Nevertheless, the
results suggest that mindfulness interventions could be benefi-
cial for people experiencing psychosocial distress and living
with a visible skin condition. Current interventions used in
dermatology reporting the largest effect sizes include habit
reversal (g = 105) and cognitive behavioural therapy (CBT)
(g = 065).24 CBT has been found to be effective in reducing
distress associated with dermatological conditions in a small
number of studies;43,44 however, these studies have limited
power due to small sample sizes. Considering social anxiety, a
significant number of patients fail to reach remission follow-
ing CBT.45 The present findings suggest that further studies
examining mindfulness techniques in dermatological popula-
tions would be beneficial. Specifically, the findings suggest
that individuals with social anxiety may benefit from using
mindfulness to (i) bring attention to the present moment and
reduce ruminative processes; and (ii) reduce the tendency of
automatically judging the content of thoughts.
The current study design has a number of limitations that
should be noted. Firstly, the cross-sectional design of this
study precludes strong conclusions being drawn about the
direction of effects. Longitudinal and interventional studies are
required to address this issue. Secondly, although studies sug-
gest that objective severity is not an accurate indicator of dis-
tress,46,47 as all measures used were self-reported, future
studies might seek to gain clinician ratings of severity. Thirdly,
as the sample was predominantly white and female, some cau-
tion should be exhibited about the generalizability of the find-
ings. Furthermore, this prevented an examination of sex
differences in distress and mindfulness. Finally, the fact that
the sample was drawn from a specialist dermatology clinic
also places boundaries on the generalizability of the results.
In conclusion, the findings of this study suggest that higher
levels of mindfulness, particularly awareness, are associated
with reduced psychosocial distress and improved dermatologi-
cal quality of life. Mindfulness explained the highest propor-
tion of variance in social anxiety in this study, which suggests
that mindfulness interventions might be used to target social
anxiety associated with skin conditions. While the results
should be interpreted with caution given the cross-sectional
nature of the study, the findings offer evidence that increasing
mindfulness may be helpful in reducing distress in people liv-
ing with visible skin conditions.
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